GB201310946D0 - Antidote - Google Patents
AntidoteInfo
- Publication number
- GB201310946D0 GB201310946D0 GB201310946A GB201310946A GB201310946D0 GB 201310946 D0 GB201310946 D0 GB 201310946D0 GB 201310946 A GB201310946 A GB 201310946A GB 201310946 A GB201310946 A GB 201310946A GB 201310946 D0 GB201310946 D0 GB 201310946D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antidote
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201310946A GB201310946D0 (en) | 2013-06-19 | 2013-06-19 | Antidote |
PCT/GB2014/051890 WO2014202991A1 (en) | 2013-06-19 | 2014-06-19 | Antidote |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201310946A GB201310946D0 (en) | 2013-06-19 | 2013-06-19 | Antidote |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201310946D0 true GB201310946D0 (en) | 2013-07-31 |
Family
ID=48914823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201310946A Ceased GB201310946D0 (en) | 2013-06-19 | 2013-06-19 | Antidote |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201310946D0 (en) |
WO (1) | WO2014202991A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015305413B2 (en) * | 2014-08-20 | 2020-09-24 | Alexion Pharmaceuticals, Inc. | Lyophilized formulations for factor xa antidote |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007106893A2 (en) * | 2006-03-15 | 2007-09-20 | Emory University | Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
-
2013
- 2013-06-19 GB GB201310946A patent/GB201310946D0/en not_active Ceased
-
2014
- 2014-06-19 WO PCT/GB2014/051890 patent/WO2014202991A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014202991A1 (en) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3689865T3 (en) | Hidtil ukendte aminopyrimidinderivater | |
DK3088517T3 (en) | Humant anti-il-33-neutraliserende monoklonalt antistof | |
DK3736291T3 (en) | Anti-FCRH5-antistoffer | |
DK3354246T3 (en) | Udstyrsmonteringssystem | |
DK3077519T3 (en) | Cmv-vacciner | |
EP3000028A4 (en) | Auto-calendaring | |
EP2957205A4 (en) | Hand-dryer | |
DK3470074T3 (en) | Probiotika | |
EP2970310A4 (en) | 5-bromo-indirubins | |
EP2853297A4 (en) | Kendama | |
EP2975313A4 (en) | Fluid-throttling member | |
AU353576S (en) | Stamphousing | |
DK3056208T3 (en) | Immunpotentiator | |
DK2979701T3 (en) | Antitumormiddel indbefattende irinotecanhydrochloridhydrat | |
GB201310946D0 (en) | Antidote | |
EP3014557A4 (en) | Phone-on-file | |
GB201300001D0 (en) | Envirep - environment replicater | |
DK2989854T3 (en) | Strømstyret opvarmningssystem | |
AU4899P (en) | Herbie53 Iresine herbstii | |
AU4953P (en) | Flogazora Gazania rigens | |
AU4977P (en) | Harrosy Gaura lindheimeri | |
AU353328S (en) | Kettlebell | |
AU353327S (en) | Kettlebell | |
AU353326S (en) | Kettlebell | |
AU353331S (en) | Kettlebell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |